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fibroblast-like features, characterized by increased cell 
proliferation, motility, contractility and the production 
of extra-cellular matrix1), 2).  Activation of HSCs is regu-
lated by several cytokines and growth factors, includ-
ing platelet-derived growth factor (PDGF), a most po-
tent mitogen for HSCs3).
　PDGF family members, PDGF-A, -B, and newly dis-
1.Introduction
　Hepatic fibrosis is a common response to chronic liv-
er insults such as ethanol, viral infection, cholestasis and 
metabolic disease.  One of the hallmarks of hepatic fi-
brosis is the activation of hepatic stellate cell (HSCs). 
Following liver injury of any etiology, HSCs undergo 
phenotypic transformation with the acquisition of myo-
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Abstract
　Background/Aims: Platelet-derived growth factor (PDGF) is implicated in the activation of hepatic 
stellate cells (HSCs), the key cell population in liver fibrogenesis.  We depleted the expression of PDGF 
receptor-ß (PDGFR-ß) and assessed the role in the activation of HSCs.  Methods: We used the wild-
type and mutant mice whose PDGFR-ß gene was flanked by two loxP sequences, and isolated/cul-
tured HSCs from these two mice, respectively.  These cells were infected with Cre recombinase-ex-
pressing adenovirus.  Results: After Cre-adenovirus infection, PDGFR-ß expression was depleted in 
HSCs from mutant mice (PDGFR-ß∆/∆), but was preserved in those from wild-type.  We detected the 
expression of PDGFR-α and PDGF-A, -B, -C, and -D at similar levels between WT and PDGFR-ß∆/∆. 
BrdU-incorporation in PDGFR-ß∆/∆ was suppressed in serum-starved/non-stimulated and PDGF-BB 
stimulated conditions, respectively. PDGF-BB-induced wound closure was apparently delayed in PDG-
FR-ß∆/∆.  α１ (I) collagen mRNA was low in PDGFR-ß∆/∆, sparing α-smooth muscle actin mRNA at WT 
levels.  Conclusions: The HSCs expressed two types of PDGFR; however, PDGFR-ß was distinctively 
relevant in the activation of HSCs by mediating both endogenous and exogenous PDGF signals.
和文要旨
　血小板由来増殖因子（PDGF）は肝臓の線維症を誘導する肝星細胞（HSC）を活性化する。本研究で
はHSCにおけるPDGFベータ受容体（PDGFR-ß）の発現を抑制し，その機能を評価した。野生型と
LoxP配列を挿入したPDGFR-ß遺伝子をそれぞれ有するマウスからHSCを分離培養した。双方の細胞に
Cre遺伝子組み換え酵素を発現するアデノウイルスを感染させ，後者の細胞のPDGFR-ß遺伝子を不活化
した（＝PDGFR-ß∆/∆）。PDGFR-α，PDGF-A，-B，-Cおよび-Dのいずれもが，両細胞で同程度に発現し
た。野生型に比較し，PDGFR-ß∆/∆細胞の増殖活性は低く，α １ (I)コラーゲンの産生と創傷治癒能力も低
下した。PDGFR-ßはHSCにおけるPDGFのパラクラインおよびオートクラインを介するシグナルを伝達
し，肝臓線維症にかかわるHSCの機能を活性化した。
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the PDGF system in liver fibrosis.
2.Materialsandmethods
2.1.Animals
　The F1 progenies, carrying a recombinant allele of 
PDGFR-ß (PDGFR-ßflox/+), were generated previously18), 
and were crossbred with wild-type C57BL/6 mice 5 
times.  Then, we obtained homozygous mutants (PDG-
FR-ßflox/flox) by sister-brother inbreeding.  All animals 
received animal care according to the Institutional Ani-
mal Care and Use Committee at University of Toyama.
2.2.IsolationandcultureofmouseHSCs
　The HSCs were isolated from mice of 4 to 5-months-
old by perfusion of collagenase (Rosche Applied Science, 
Indianapolis, IN) and pronase (Wako Pure Chemical Co., 
Osaka, Japan), followed by centrifugation over Nyco-
denz gradient (Nycomed Pharma AS, Oslo, Norway), as 
described previously19).  After isolation, the cells were 
plated at a density of 2 x 105 cells/35 mm plastic dish 
and were cultured in Dulbecco’s modified Eagle’s medi-
um (DMEM, Nissui Pharmaceutical Co., Ltd., Tokyo, Ja-
pan), supplemented with 10% Fetal Bovine Serum (FBS, 
BioWhittaker A Cambrex Inc., Walkerville, MD) and 
antibiotics (105 U/l penicillin G, 100mg/l streptomycin). 
HSCs were identified by the typical star-like configura-
tion and vitamin A autofluorescence, and the purity 
was higher than 99%.
2.3.Adenovirus
　Cre expressing adenovirus, AxCANCre, was gener-
ously provided by Dr. Izumu Saito (University of To-
kyo, Japan)20) and RIKEN, BioResource Center (Ibaraki, 
Japan).  Cre recombinase was transfected into HSCs by 
AxCANCre as described previously18).  The HSCs were 
infected on day 1 of culture.
2.4.Westernblotting
　Proteins were prepared from HSCs cultured in 
DMEM supplemented with 10% FBS from days 2 to 8. 
In other experiments, proteins were prepared from 
HSCs stimulated for 10 min by PDGF-BB (10 ng/ml; 
Invitrogen, Carlsbad, CA) after 24 h-starvation within 
DMEM supplemented with 0.5% FBS.  The preparation 
of protein lysates, Western-blotting and following detec-
tion procedures were performed as described previous-
ly18), 21).  A total of 5 µg of protein was run on each lane 
and was blotted with the antibodies, as listed in table 1.
covered PDGF-C, and -D, are assembled as disul-
fide-linked homo- or heterodimers and exert their activ-
ity by binding to and activating specific high affinity 
cell surface receptors4)-7).  Two receptor tyrosine kinas-
es, PDGFR-α and -ß, that can form homo- and heterodi-
meric receptor complexes have been identified.  The 
PDGFR-αα can be specifically activated by PDGF-AA, 
-AB, -CC and -BB; PDGFR-αß by PDGF-AB, -BB and 
-CC; PDGFR-ßß by PDGF-BB and -DD.  Depending of 
the cell type, these ligands and receptors are expressed 
at various levels and function in paracrine and auto-
crine mechanisms8).
　It has been reported that PDGF-A and -B and PDG-
FR-α and -ß are upregulated in both human cirrhotic 
liver tissues and experimental rat liver fibrosis9)-11).  The 
induction of PDGFR-ß expression is assumed to be an 
early event in HSC activation in vitro and in vivo and 
to be a crucial initiation step of liver fibrosis11)-13).  Based 
on these reports, several therapeutic trials to inhibit the 
PDGF system have been successfully conducted to pre-
vent experimentally induced liver fibrosis13)-15).  On the 
other hand, the hepatic overexpression of either 
PDGF-B or PDGF-C by a transgenic strategy was re-
cently reported to induce liver fibrosis16),17).  The in-
volvement of PDGFR-α as well as PDGFR-ß is necessary 
for the pathogenesis of PDGF-CC induced liver fibrosis, 
because PDGF-CC binds to PDGFR-αα and -αß but not 
-ßß.  Thus, the multiple PDGF ligands and receptors are 
involved and are assumed to be important for the liver 
fibrogenesis; however, the precise mechanism still re-
mains unknown.
　Previously, we established a PDGFR-ßflox/flox mouse 
line in which two loxP sequences are inserted into the 
intron of the PDGFR-ß genomic sequence, and selective-
ly depleted PDGFR-ß in cultured dermal fibroblasts by 
Cre-transfection18).  PDGFR-ß depleted fibroblasts 
showed decreased migratory and proliferative respons-
es that are important for the wound healing of the skin. 
Our data on these cells indicated a distinctive role of 
PDGFR-ß that differs from PDGFR-α.
　Although the HSCs are known to express both PDG-
FR-α and -ß mRNA12), the functional role of each recep-
tor in this specific cell type is yet to be determined.  In 
the present study, we isolated HSCs from PDGFR-ßflox/
flox mouse, and selectively depleted their PDGFR-ß ex-
pression by introducing Cre recombinase using an ade-
novirus-vector.  Then, we sought to determine the dis-
tinctive role of PDGFR-ß in the activation process of 
HSCs, for the clarification of the functional relevance of 
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followed by 40 cycles at 95˚C for 10 sec and 60˚C for 40 
sec.  The threshold cycle values were calculated, and 
transcript levels were then standardized against GAP-
DH levels.  Sequences of the primers are listed in Table 
2.  The average efficiency of all PCR reactions was more 
than 90%.
2.7.Proliferationassay
　Proliferative activity was measured by nuclear label-
ing of HSCs with 5-bromo-2’-deoxyuridine (BrdU) on the 
indicated days.  The HSCs were serum-starved in 
DMEM supplemented with 0.5 % FBS for 24 h, then 
HSCs were incubated with BrdU (10 mmol/l) and with 
or without 10 ng/ml of PDGF-BB in starvation medium 
for another 24 h.  BrdU-incorporation was detected ac-
cording to the manufacturer’s instructions (BrdU detec-
tion kit I, Roche Diagnostics GmbH).  The proportion of 
BrdU- positive nuclei was calculated by counting at 
least 500 cells in the specified number of independent 
2.5.Immunofluorescentstaining
　HSCs cultured on 4-well chamber glass slides were 
fixed with cold acetone for 10 min on day 2-8, and im-
munostained for PDGFR-ß and α-smooth muscle actin 
(α-SMA) using antibody listed in Table 1.  Detection and 
visualization were previously described18), 21).
2.6.RNAisolationandRT-PCRforPDGF-ligands,col-
lagen,andα-SMA
　Total RNA was isolated using a RNeasy mini kit (Qia-
gen, Hiden, Germany) from HSCs on the indicated days, 
and 0.2 µg of RNA was reverse transcribed using Ex-
Script RT reagent Kit (TAKARA, Shiga, Japan) accord-
ing to the manufacturer’s instructions.  The expression 
of PDGF-A, -B, -C, -D, α1 (I) collagen, α-SMA, and GAP-
DH mRNA was evaluated by quantitative RT-PCR anal-
ysis using the SYBR Premix Ex Taq (TAKARA) and 
Mx3000P (Stratagene, La Jolla, CA).  All reactions were 
run in triplicate with an initial 10 sec activation at 95˚C, 
Table1　PrimaryantibodiesforWesternblottingandimmunofluorescentstaining
Table2　ForwardandreverseprimerusedforrealtimePCRanalysis
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3.Results
3.1.Cre-transfectiondepletedtheexpressionofPDG-
FR-ßproteininPDGFR-ßflox/floxHSCs
　We first investigated whether Cre-expressing adeno-
virus infection could abrogate the expression of PDG-
FR-ß in HSCs isolated from PDGFR-ßflox/flox mice.  On 
Western blots, cultured HSCs isolated from wild-type 
mice expressed PDGFR-α and -ß at all time points ex-
amined, and most abundantly on day 2 (Fig. 1A).  The 
expression of PDGFR-ß was undetectable in HSCs iso-
lated from PDGFR-ßflox/flox mice after Cre transfection, 
and we designated these HSCs depleted in PDGFR-ß 
expression as PDGFR-ß∆/∆.  The expression of PDGFR-α 
in PDGFR-ß∆/∆ HSCs was at similar levels to that in 
wild-type.  In immunofluorescent analyses, most of the 
wild-type HSCs were labeled for PDGFR-ß throughout 
the experimental periods, most intensely on day 2 (Fig. 
1B).  The immunoreactivities for PDGFR-ß disappeared 
in almost all of HSCs isolated from PDGFR-ßflox/flox mice 
experiments.
2.8.Woundscratchassay
　HSCs were cultured in uncoated 12-well plastic plates 
in DMEM supplemented with 10% FBS, allowing them 
to reach a sub-confluent state.  After serum-starvation 
for 24 h, the cells were scratched with a 100 µl plastic 
pipette tip.  Then, the cells were cultured in DMEM 
supplemented with 10 ng/ml PDGF-BB, and the wound 
closure was observed after 48 h using an inverted phase 
contrast microscope (Olympus CK30) and photographed.
2.9.Statisticalanalysis
All values are presented as means ±S.E.M.  ANOVA 
and Student’s t test were used to determine the p val-
ues, and p < 0.05 was considered statistically significant.
Fig.1.DepletionofPDGFR-ßproteinexpression inHSCsafterCre-transfection.
(A)Wild-typeandPDGFR-ßflox/floxHSCswereinfectedwithCre-expressingadenovi-
rusonday1(abbreviatedasWTandPDGFR-ß∆/∆,respectively).Wholecelllysates
wereharvestedontheindicateddaysandwereimmunoblottedwithanti-PDGFR-α,
anti-PDGFR-ß,andGAPDHantibodies.(B,C)HSCs,infectedwithCre-expressing
adenoviruswereimmunostainedwithanti-PDGFR-ß(B,green)andα-SMAantibody
(C,red)ontheindicateddaysofculture.ThecellswerecounterstainedwithDAPI
(blue). Eachfigurewaspreparedat the samemagnification. Scalemicronbar
represents50µm.Representativeimmunofluorescentstainingisshown.
MORITA et al：PDGFR-ß in hepatic stellate cell 17
tively high in serum-starved and unstimulated condi-
tion on days 4, 6 and 8, and in a small percentage of cells 
on day 10 (Fig. 3).  In wild-type HSCs, PDGF-BB stimu-
lation significantly enhanced BrdU-incorporation on 
days 6 and 8, but not on days 4 and 10.
　In PDGFR-ß∆/∆ HSCs, the percentage of BrdU-incorpo-
ration in serum-starved and unstimulated condition was 
extremely low on days 4 and 10 compared to that in 
days 6 and 8 (Fig. 3).  In these conditions, the percent-
age of BrdU-positive cells was significantly lower in 
PDGFR-ß∆/∆ HSCs than in wild-type HSCs on days 4 and 
6.  PDGF-BB stimulation did not enhance BrdU-incorpo-
ration in PDGFR-ß∆/∆ HSCs throughout the experiment.
3.4.PDGFR-ßdepletionattenuatedPDGF-BBinduced
cellmigrationofHSCs
　The effect of PDGFR-ß depletion was elucidated on 
the closure of a scratched wound in vitro.  In this assay, 
PDGF-BB induced the migration of wild-type HSCs, re-
sulting in complete wound closure 48 h after scratching 
(Fig. 4A and 4B).  In the same conditions, the migratory 
response in PDGFR-ß∆/∆ HSCs was quite limited com-
after Cre transfection throughout the experimental pe-
riods (Fig. 1B).
　Both wild-type and PDGFR-ß∆/∆ HSCs survived and 
showed activated phenotypes typical to HSCs in vitro: 
both types of cells enlarged, became polygonal in shape, 
and showed increased immunoreactivity for α-SMA as 
a function of culture duration (Fig. 1C).
3.2.AllPDGF-ligandswereendogenouslysynthesized
inHSCs.
　The mRNA expression levels of four PDGF-ligands 
(PDGF-A, -B, -C, and -D) were elucidated by quantita-
tive RT-PCR (Fig. 2).  The mRNA of all four ligands was 
detected on days 4 and 8, and there was no significant 
difference in the levels of mRNA expression between 
the two types of HSCs.
3.3.PDGFR-ßdepletiondecreasedDNAsynthesisof
HSCs
　The effect of PDGFR-ß depletion was elucidated 
through the mitogenic activity of HSCs.  In wild-type 
HSCs, the percentage of BrdU-positive cells were rela-
Fig.2.EffectofPDGFR-ßdepletiononPDGFligandexpressioninHSCs.
Wild-typeandPDGFR-ßflox/floxHSCswereinfectedwithCre-expressingadenoviruson
day1(abbreviatedasWTandPDGFR-ß∆/∆,respectively),andtotalRNAwasisolated
asdescribedinMaterialsandMethods.PDGF-A,-B,-C,and-DmRNAswerequan-
tifiedbyRT-PCR.ThelevelofeachmRNAwasexpressedasfold-increaseofthat
ofGAPDHmRNA.Valuesareexpressedasmeans±S.E.M.ofmorethanfourinde-
pendentexperiments.
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Fig.3.EffectofPDGFR-ßdepletiononDNAsynthesisinHSCs.
Wild-typeandPDGFR-ßflox/floxHSCswereinfectedwithCre-expressingadenovirusonday1
(abbreviatedasWTandPDGFR-ß∆/∆,respectively).Proliferativeactivitywasmeasuredby
theincorporationofBrdUbyHSCsontheindicateddays.TheHSCswereserum-starvedin
DMEMsupplementedwith0.5%FBSfor24h,thenHSCswereincubatedwithBrdUand
withorwithout10ng/mlofPDGF-BBinstarvationmediumforanother24h.Thepercent-
ageofBrdUpositivenucleiwasdeterminedbycountingatleast500cellsinindependent
experiments.Valuesareexpressedasmeans±S.E.M.offour independentexperiments.
Differenceswereconsideredassignificant(*)atp<0.05,or(**)atp<0.01.
Fig.4.EffectofPDGFR-ßdepletiononwoundscratchassay.
Wild-type (WT) and PDGFR-ßflox/flox HSCs (PDGFR-ß∆/∆) were infected with
Cre-adenovirusonday1:WT(A,B),PDGFR-ß∆/∆ (C,D),andwereculturedto
reachasub-confluentstate.TheHSCswereserum-starvedinDMEMsupple-
mentedwith0.5%FBSfor24h,andthemonolayeroftheculturewassubjected
toscratchinjurywithaplasticpipettetip(A,C).Thecellswerethentreatedwith
10ng/mlPDGF-BBinstarvationmediumfor48h(B,D).Largeblackdotsindi-
catestartingpointsofmigration.Representativeimagesareshownfromthree
separateexperiments.
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er in PDGFR-ß∆/∆ HSCs on day 6; however, there was no 
significant difference between the two types of HSCs 
throughout the experiment.
4.Discussion
　The present study was conducted to clarify the func-
tional relevance of PDGFR-ß in the activation of HSCs, 
which is a central phenomenon of liver fibrogenesis.
　PDGFR-ß expression is upregulated at day 1 in HSCs, 
and decreased to normal levels at days 7-12 after liver 
injuries induced by CCl4 administration or by bile duct 
ligation11).  In the present study, PDGFR-α and -ß were 
expressed abundantly during the early days of culture, 
and decreased afterwards in wild-type HSCs.  Cre 
transfection selectively depleted PDGFR-ß in PDG-
FR-ßflox/flox HSCs without affecting the expression of 
PDGFR-α.  Through the culture periods, our wild-type 
and PDGFR-ß∆/∆ HSCs showed the morphologic features 
typical to the transdifferentiation into myofibroblast-like 
cells, such as loss of fat droplets, increased cytoplasmic 
extensions, and α-SMA expression22).  Taken together, 
our culture system seems to reproduce the early activa-
tion process of HSCs after liver injury, and allowed us 
to analyze the role of PDGFR-ß in the activation of 
HSCs in liver fibrosis.
　PDGF is the most potent mitogen for HSCs3).  In our 
study, PDGF-BB significantly induced the BrdU-incor-
poration in wild-type HSCs but not in PDGFR-ß∆/∆ HSCs. 
pared to the wild-type, and the scratched wound re-
mained unclosed after 48 h (Fig. 4C and 4D).
3.5.PDGFR-ßdepletiondecreasedcollagenbutnot
α-SMAsynthesisinHSCs
　The effects of PDGFR-ß depletion on the expression 
of α 1(I) collagen and α-SMA genes, were elucidated, as 
indices of fibrogenesis and myofibroblastic differentia-
tion of HSCs, respectively.  In wild-type HSCs, α 1(I) 
collagen mRNA was expressed at low levels on day 2, 
as shown by real-time RT-PCR analysis (Fig. 5).  After-
wards, the corresponding mRNA increased linearly in 
these cells until day 8.
　In PDGFR-ß∆/∆ HSCs, the time course of α 1(I) collagen 
mRNA expression was significantly different from wild-
type as confirmed by the ANOVA-test for interaction 
between time and genotype (p = 0.012).  The gene ex-
pression in PDGFR-ß∆/∆ was low on day 2 and increased 
on day 4, at similar levels to those detected in wild-type 
HSCs (Fig. 5A).  Afterwards, α 1(I) collagen gene expres-
sion level in PDGFR-ß∆/∆ was significantly lower on days 
6 (p = 0.030) and 8 (p = 0.012) compared to wild-type 
HSCs.
　In both types of HSCs, α-SMA gene expression was at 
low levels on day 2 and tended to increase afterwards 
(Fig. 5B).  This tendency was similar to the findings 
obtained in the immunofluorescence staining analysis of 
HSCs (Fig. 1C).  This gene expression was slightly low-
Fig.5.EffectofPDGFR-ßdepletiononcollagenanda-SMAsynthesisinHSCs.
Wild-typeandPDGFR-ßflox/floxHSCswereinfectedwithCre-expressingadenovirusonday2(WT,closedbar;
PDGFR-ß∆/∆,openbar),andtotalRNAwasisolatedasdescribedinMaterialsandMethods.a1(I)collagen(A)
andα-SMA(B)mRNAswerequantifiedbyRT-PCR.ThelevelofeachmRNAwasexpressedasfold-increase
ofthatofGAPDHmRNA.Valuesareexpressedasmeans±S.E.M.ofthreeindependentexperiments.Differ-
enceswereconsideredassignificant(*)atp<0.05.
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one of the specific targets regulated by PDGFR-ß be-
cause the expression of α-SMA was not affected.
　Within the therapeutic trials against liver fibrosis, 
PDGF is one of the most important targets to prevent 
HSC activation1).  Imatinib mesylate decreased rat HSC 
proliferation13) and reduced rat liver fibrosis14).  Neutral-
ization of PDGF activity, by ligand antagonists or recep-
tor blockade, prevented experimentally induced liver 
fibrogenesis27), 28), 15).  The distinctive role of PDGFR-ß in 
HSCs, demonstrated in the current study, was strongly 
supportive for these therapeutic trials targeting 
PDGF-B in liver fibrosis.  It is noteworthy that PDG-
FR-ß depletion is potentially preventive against PDGF-C 
induced liver fibrosis as well, because PDGF-CC binds 
PDGFR-αß and HSCs express PDGFR-α and -ß12), 17).
　In summary, we analyzed the early activation pro-
cesses of primary cultured HSCs in which selective 
PDGFR-ß depletion was induced by genetic manipula-
tion based on Cre loxP system.  These cells showed 
morphological features indicating transdifferentiation to 
myofibroblastic cells.  However, they showed much low-
er activity to proliferate, migrate and express the colla-
gen gene.  The distinctive role of PDGFR-ß was demon-
strated for the activation of HSCs, and it was suggested 
this receptor could be a promising target for the pre-
vention and cure of liver fibrogenic disease that seems 
to be induced by PDGF-B and/or PDGF-C.
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In contrast, PDGF-BB did not induce BrdU-incorpora-
tion in PDGFR-ß∆/∆ HSCs in spite of the PDGFR-α ex-
pression in these cells.  It was also noteworthy that the 
BrdU-incorporation in serum-starved and non-stimu-
lated condition was strikingly higher in wild-type than 
in PDGFR-ß∆/∆ on days 4 and 6.  We detected the syn-
thesis of PDGF-ligands in two types of HSCs.  These 
facts strongly suggest the existence of an autocrine-loop 
of growth signals in HSCs, that signal is mediated by 
PDGFR-ß to sustain BrdU-incorporation even in a se-
rum-starved condition.  Furthermore, PDGF-BB did not 
induce BrdU-incorporation in wild-type HSCs on day 4. 
Accordingly, the endogenously synthesized growth-sig-
nal mediated by PDGFR-ß may contribute to trigger 
the initial HSC growth after liver injury.  Thus, BrdU-in-
corporation induced by both exogenous and endoge-
nous PDGF stimuli was well correlated to the level of 
PDGFR-ß but not PDGFR-α, and it was clearly demon-
strated that PDGFR-ß, but not PDGFR-α, is important 
for HSC proliferation.
　In the present study, depletion of PDGFR-ß strikingly 
inhibited PDGF-BB induced wound closure by HSCs, a 
process depends on both migratory and proliferative 
response of the cells.  We conducted this assay using 
HSCs cultivated for at least 10 days when both types of 
HSC showed similarly low levels of proliferative activi-
ty.  Accordingly, the decreased wound closure in PDG-
FR-ß∆/∆ seems to be attributed to the deficit of the mi-
gratory response induced by the depletion of PDGFR-ß. 
Together with the facts showing that PDGF-BB, not 
PDGF-AA, stimulates HSC chemotaxis23), our current 
data showed PDGFR-ß plays an exclusively important 
role in the migratory cell response.  Thus, PDGFR-ß 
may be implicated as a contributing factor to stimulate 
HSC migration from the sinusoidal wall to the damaged 
region24)-26), in the pathogenesis of liver fibrosis.
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dominant-negative soluble PDGFR-ß reduced α 1(I) col-
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HSCs cultured in DMEM supplemented with 10% FBS 
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mRNA levels.  Collectively, it was suggested that PDG-
FR-ß signal is crucial for expression of the α 1(I) collagen 
gene during the HSC activation, and that this gene is 
MORITA et al：PDGFR-ß in hepatic stellate cell 21
18) Gao Z., Sasaoka T., Fujimori T. et al. : Deletion of the 
PDGFR-beta gene affects key fibroblast functions import-
ant for wound healing, J Biol Chem. 280 : 9375-9389, 2005.
19) Kawada N., Kuroki T., Kobayashi K. et al. : Expression of 
heat-shock protein 47 in mouse liver, Cell Tissue Res. 284 
: 341-346, 1996.
20) Kanegae Y., Takamori K., Sato Y. et al. : Efficient gene 
activation system on mammalian cell chromosomes using 
recombinant adenovirus producing Cre recombinase, 
Gene. 181 : 207-212, 1996.
21) Ishii Y., Oya T., Zheng L. et al. : Mouse brains deficient 
in neuronal PDGF receptor-beta develop normally but are 
vulnerable to injury, J Neurochem. 98 : 588-600, 2006.
22) Bachem MG., Meyer D., Schafer W. et al. : The response 
of rat liver perisinusoidal lipocytes to polypeptide growth 
regulator changes with their transdifferentiation into my-
ofibroblast-like cells in culture, J Hepatol. 18 : 40-52, 1993.
23) Marra F., Gentilini A., Pinzani M. et al. : Phosphatidyli-
nositol 3-kinase is required for platelet-derived growth 
factor’s actions on hepatic stellate cells, Gastroenterology. 
112 : 1297-1306, 1997.
24) Grappone C., Pinzani M., Parola M. et al. : Expression of 
platelet-derived growth factor in newly formed cholangio-
cytes during experimental biliary fibrosis in rats, J Hepa-
tol. 31 : 100-109, 1999.
25) Kinnman N., Hultcrantz R., Barbu V. et al. : PDGF-medi-
ated chemoattraction of hepatic stellate cells by bile duct 
segments in cholestatic liver injury, Lab Invest. 80 : 697-
707, 2000. 
26) Ikeda K., Wakahara T., Wang YQ. et al. : In vitro migra-
tory potential of rat quiescent hepatic stellate cells and its 
augmentation by cell activation, Hepatology. 29 : 1760-
1767, 1999.
27) Borkham-Kamphorst E., Herrmann J., Stoll D. et al. : 
Dominant-negative soluble PDGF-beta receptor inhibits 
hepatic stellate cell activation and attenuates liver fibro-
sis, Lab Invest. 84 : 766-777, 2004. 
28) Borkham-Kamphorst E., Stoll D., Gressner AM. et al. : 
Inhibitory effect of soluble PDGF-beta receptor in cul-
ture-activated hepatic stellate cells, Biochem Biophys Res 
Commun. 317 : 451-462, 2004.
on DNA synthesis and growth of cultured rat liver 
fat-storing cells, J Clin Invest. 84 : 1786-1793, 1989. 
4) Hart CE., Forstrom JW., Kelly JD. et al. : Two classes of 
PDGF receptor recognize different isoforms of PDGF, Sci-
ence. 240 : 1529-1531, 1988. 
5) Gilbertson DG., Duff ME., West JW. et al. : Platelet-derived 
growth factor C (PDGF-C), a novel growth factor that 
binds to PDGF alpha and beta receptor, J Biol Chem. 276 
: 27406-27414, 2001.
6) LaRochelle WJ., Jeffers M., McDonald WF. et al. : PDGF-D, 
a new protease-activated growth factor, Nat Cell Biol. 3 : 
517-521, 2001. 
7) Bergsten E., Uutela M., Li X. et al. : PDGF-D is a specific, 
protease-activated ligand for the PDGF beta-receptor, Nat 
Cell Biol. 3 : 512-516, 2001. 
8) Heldin CH., Backstrom G., Ostman A. et al. : Binding of 
different dimeric forms of PDGF to human fibroblasts: ev-
idence for two separate receptor types, EMBO J. 7 : 1387-
1393, 1988.
9) Pinzani M., Milani S., Herbst H. et al. : Expression of plate-
let-derived growth factor and its receptors in normal hu-
man liver and during active hepatic fibrogenesis, Am J 
Pathol. 148 : 785-800, 1996.
10) Ikura Y., Morimoto H., Ogami M. et al. : Expression of 
platelet-derived growth factor and its receptor in livers of 
patients with chronic liver disease, J Gastroenterol. 32 : 
496-501, 1997.
11) Wong L., Yamasaki G., Johnson RJ. et al. : Induction of 
beta-platelet-derived growth factor receptor in rat hepat-
ic lipocytes during cellular activation in vivo and in cul-
ture, J Clin Invest. 94 : 1563-1569, 1994. 
12) Breitkopf K., Roeyen C., Sawitza I. et al. : Expression 
patterns of PDGF-A, -B, -C and -D and the PDGF-recep-
tors alpha and beta in activated rat hepatic stellate cells 
(HSC), Cytokine. 31 : 349-357, 2005.
13) Kinnman N., Goria O., Wendum D. et al. : Hepatic stellate 
cell proliferation is an early platelet-derived growth fac-
tor-mediated cellular event in rat cholestatic liver injury, 
Lab Invest. 81 : 1709-1716, 2001. 
14) Yoshiji H., Noguchi R., Kuriyama S. et al. : Imatinib 
mesylate (STI-571) attenuates liver fibrosis development 
in rats, Am J Physiol Gastrointest Liver Physiol. 288 : 
G907-913, 2005. 
15) Borkham-Kamphorst E., Stoll D., Gressner AM. et al. : 
Antisense strategy against PDGF B-chain proves effec-
tive in preventing experimental liver fibrogenesis, Bio-
chem Biophys Res Commun. 321 : 413-423, 2004.
16) Czochra P., Klopcic B., Meyer E. et al. : Liver fibrosis in-
duced by hepatic overexpression of PDGF-B in transgenic 
mice, J Hepatol. 45 : 419-428, 2006.
17) Campbell JS., Hughes SD., Gilbertson DG. et al. : Plate-
let-derived growth factor C induces liver fibrosis, steato-
sis, and hepatocellular carcinoma, Proc Natl Acad Sci U S 
A. 102 : 3389-3394, 2005. 
22 Toyama Medical Journal　Vol. 27　No. 1　2016
